USNANYSEMedicinal Chemicals & Botanical ProductsFiscal year ends January 3

USANA HEALTH SCIENCES INC

Financials through Q2 FY2026, quarter ended Jul 4, 2026Last filing: 10-Q on Aug 13, 2026

$14.89−0.65 (-4.18%)

Close on Oct 19, 2026

Community

Notes and questions about Usana Health Sciences from other investors

Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.

Parsed from the XBRL in Usana Health Sciences's annual and quarterly filings with the SEC
Per-share figures adjusted for the 2-for-1 split on Nov 23, 2016
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is USNA.

Revenue growth1.6% · median 8.3%

Gross margin77.4% · median 29.1%

Operating margin-0.1% · median 2.5%

Net margin-2.4% · median -6.9%

Advertisement
300 × 250